Market icon

Flu Hospitalization Rate Week 13, 2026?

Market icon

Flu Hospitalization Rate Week 13, 2026?

Apr 10

Apr 10

80–85 96%

85–90 2.0%

<70 1.6%

70–75 1.6%

Polymarket
NEW

80–85 96%

85–90 2.0%

<70 1.6%

70–75 1.6%

Polymarket
NEW

<70

$404 Vol.

2%

70–75

$295 Vol.

2%

75–80

$133 Vol.

1%

80–85

$255 Vol.

96%

85–90

$43 Vol.

2%

90+

$873 Vol.

1%

This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week. If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket. The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket. Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.The latest CDC FluSurv-NET data for week 12 (ending March 28, 2026) reports a cumulative laboratory-confirmed influenza hospitalization rate of 82.7 per 100,000 population—the third highest since 2010—up from 81.6 the prior week amid declining weekly rates of 0.8 per 100,000 (estimated 1.0–1.4 after lags). This positions traders' 95.5% implied probability on 80–85 for week 13 (ending April 4), as FluSight ensemble forecasts just 0.5 weekly admissions per 100,000 nationally, suggesting a modest rise to around 83–84. Supporting evidence includes nationwide drop in influenza activity and low test positivity, reflecting season's end. Challenges could arise from reporting delays inflating figures or unforeseen regional surges, though models indicate low risk ahead of next FluView release.

This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.

If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.

The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.

Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
Volume
$2,002
End Date
Apr 10, 2026
Market Opened
Apr 3, 2026, 12:08 PM ET

Resolver

0x69c47De9D...
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week. If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket. The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket. Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week. If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket. The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket. Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.The latest CDC FluSurv-NET data for week 12 (ending March 28, 2026) reports a cumulative laboratory-confirmed influenza hospitalization rate of 82.7 per 100,000 population—the third highest since 2010—up from 81.6 the prior week amid declining weekly rates of 0.8 per 100,000 (estimated 1.0–1.4 after lags). This positions traders' 95.5% implied probability on 80–85 for week 13 (ending April 4), as FluSight ensemble forecasts just 0.5 weekly admissions per 100,000 nationally, suggesting a modest rise to around 83–84. Supporting evidence includes nationwide drop in influenza activity and low test positivity, reflecting season's end. Challenges could arise from reporting delays inflating figures or unforeseen regional surges, though models indicate low risk ahead of next FluView release.

This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.

If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.

The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.

Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
Volume
$2,002
End Date
Apr 10, 2026
Market Opened
Apr 3, 2026, 12:08 PM ET

Resolver

0x69c47De9D...
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week. If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket. The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket. Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.

Related

Market icon

Will the median home value in the US be between $433,000 and $435,000 on April 30?

19%
Market icon

Will inflation reach more than 3% in 2026?

100%
Market icon

Will the U.S. 30-year Fixed-Rate Mortgage hit 6.50% (HIGH) by December 31, 2026?

84%

Beware of external links.

Frequently Asked Questions

"Flu Hospitalization Rate Week 13, 2026?" is a prediction market on Polymarket with 6 possible outcomes where traders buy and sell shares based on what they believe will happen. The current leading outcome is "80–85" at 96%, followed by "<70" at 2%. Prices reflect real-time crowd-sourced probabilities. For example, a share priced at 96¢ implies that the market collectively assigns a 96% chance to that outcome. These odds shift continuously as traders react to new developments and information. Shares in the correct outcome are redeemable for $1 each upon market resolution.

"Flu Hospitalization Rate Week 13, 2026?" is a newly created market on Polymarket, launched on Apr 3, 2026. As an early market, this is your opportunity to be among the first traders to set the odds and establish the market's initial price signals. You can also bookmark this page to track volume and trading activity as the market gains traction over time.

To trade on "Flu Hospitalization Rate Week 13, 2026?," browse the 6 available outcomes listed on this page. Each outcome displays a current price representing the market's implied probability. To take a position, select the outcome you believe is most likely, choose "Yes" to trade in favor of it or "No" to trade against it, enter your amount, and click "Trade." If your chosen outcome is correct when the market resolves, your "Yes" shares pay out $1 each. If it's incorrect, they pay out $0. You can also sell your shares at any time before resolution if you want to lock in a profit or cut a loss.

The current frontrunner for "Flu Hospitalization Rate Week 13, 2026?" is "80–85" at 96%, meaning the market assigns a 96% chance to that outcome. The next closest outcome is "<70" at 2%. These odds update in real-time as traders buy and sell shares, so they reflect the latest collective view of what's most likely to happen. Check back frequently or bookmark this page to follow how the odds shift as new information emerges.

The resolution rules for "Flu Hospitalization Rate Week 13, 2026?" define exactly what needs to happen for each outcome to be declared a winner — including the official data sources used to determine the result. You can review the complete resolution criteria in the "Rules" section on this page above the comments. We recommend reading the rules carefully before trading, as they specify the precise conditions, edge cases, and sources that govern how this market is settled.